Cargando…
The Efficacy and Safety of a Combination of Thiocolchicoside and Etoricoxib in Low Back Pain (ESCoTEL): A Randomized Active-Controlled Trial
Background Low back pain (LBP) is a global health concern. Management of LBP aims at pain relief facilitating improvement of functional ability. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first line of therapy. However, the selection of NSAIDs is challenging given the range of underlying...
Autores principales: | Karmakar, Arnab, Arora, Sumit, Singal, Rajat, Mitra, Sandip, , Gitika, Saha, Manipa, Mitra, Monjori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681115/ https://www.ncbi.nlm.nih.gov/pubmed/38021944 http://dx.doi.org/10.7759/cureus.47621 |
Ejemplares similares
-
A comparative study of aceclofenac versus etoricoxib in the management of acute low back pain in a tertiary care hospital
por: Jagannathan, Hema, et al.
Publicado: (2020) -
Anti-inflammatory activity of lauric acid, thiocolchicoside and thiocolchicoside-lauric acid formulation
por: Mustafa, Ameena, et al.
Publicado: (2023) -
Thiocolchicoside-induced liver injury
por: Efe, Cumali, et al.
Publicado: (2011) -
Epileptic seizure after treatment with thiocolchicoside
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2009) -
The correlation of ESCO1 expression with a prognosis of prostate cancer and anti-tumor effect of ESCO1 silencing
por: Wang, Hui, et al.
Publicado: (2019)